EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis

Jacquelyn K Callander, Annabelle R Charbit, Camryn Marshall, Kritika Khanna, Steven D Pletcher iD, Jose G Gurrola iD, Andrew H Murr, Monica Tang, Andrew N Goldberg, Patricia A Loftus

International Forum of Allergy & Rhinology · 2026

DOI: 10.1002/alr.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Jacquelyn K Callander und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Eosinophilia, Eosinophil Peroxidase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Eosinophil peroxidase (EPX) correlates with local type 2 inflammation and may serve as a noninvasive biomarker of eosinophilic chronic rhinosinusitis. EPX declines after surgery and dupilumab, highlighting its potential to track treatment response. High baseline EPX predicts patients likely to achieve a clinically meaningful Sinonasal Outcome Test‐22 change.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisEosinophiliaEosinophil PeroxidaseHumansChronic DiseaseAntibodies, Monoclonal, HumanizedBiomarkersTreatment OutcomeEosinophilsMaleRhinosinusitis

Stichwörter der Autor:innen

biomarkerchronic rhinosinusitiscytokineendotypeeosinophil peroxidasenasal polyptype 2 inflammation

Substanzen

Eosinophil PeroxidaseAntibodies, Monoclonal, HumanizedBiomarkersdupilumab

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, USA.
  • Cardiovascular Research Institute, University of California, San Francisco, California, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
  • Division of Pulmonary, Critical Care, Allergy and Sleep and the Department of Medicine, University of California, San Francisco, California, USA.

ORCID-Profile: Steven D Pletcher, Jose G Gurrola

Zitieren

APA

Callander, J. K., Charbit, A. R., Marshall, C., Khanna, K., Pletcher, S. D., Gurrola, J. G., Murr, A. H., Tang, M., Goldberg, A. N., & Loftus, P. A. (2026). Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70076

Vancouver

Callander JK, Charbit AR, Marshall C, Khanna K, Pletcher SD, Gurrola JG, et al. Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70076

BibTeX
@article{Callander2026,
  author = {Callander, Jacquelyn K and Charbit, Annabelle R and Marshall, Camryn and Khanna, Kritika and Pletcher, Steven D and Gurrola, Jose G and Murr, Andrew H and Tang, Monica and Goldberg, Andrew N and Loftus, Patricia A},
  title = {Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  doi = {10.1002/alr.70076}
}
Kostenlos starten →